Scheffler, M., T. Zander, L. Nogova, C. Kobe, D. Kahraman, F. Dietlein, I. Papachristou, L. Heukamp, R. Büttner, R. Boellaard, A. A. Lammertsma, S. Querings, E. Stoelben, W. Engel-Riedel, B. Neumaier and J. Wolf: Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with Erlotinib. In: PLoS ONE 8, 1, Seq. No.: e53081 (2013).
doi: 10.1371/journal.pone.0053081
Kobe, C., M. Scheffler, A. Holstein, T. Zander, L. Nogova, A. A. Lammertsma, R. Boellaard, B. Neumaier, R. T. Ullrich, M. Dietlein, J. Wolf and D. Kahraman: Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib. In: European Journal of Nuclear Medicine and Molecular Imaging 39, 7, 1117-1127 (2012).
doi: 10.1007/s00259-012-2118-8
Kobe, C., M. Scheffler, A. Holstein, T. Zander, L. Nogova, A. A. Lammertsma, R. Boellaard, B. Neumaier, R. T. Ullrich, M. Dietlein, J. Wolf and D. Kahraman: Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib. In: European Journal of Nuclear Medicine and Molecular Imaging 39, 7, 1117-1127 (2012).
doi: 10.1007/s00259-012-2118-8
Scheffler, M., C. Kobe, T. Zander, L. Nogova, D. Kahraman, R. K. Thomas, B. Neumaier, M. Dietlein and J. Wolf: Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [ 18F]fluorothymidine (FLT-)PET. In: Lung Cancer 77, 3, 617-620 (2012).
doi: 10.1016/j.lungcan.2012.05.110
Scheffler, M., C. Kobe, T. Zander, L. Nogova, D. Kahraman, R. K. Thomas, B. Neumaier, M. Dietlein and J. Wolf: Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [ 18F]fluorothymidine (FLT-)PET. In: Lung Cancer 77, 3, 617-620 (2012).
doi: 10.1016/j.lungcan.2012.05.110
Galldiks, N., W. von Tempelhoff, D. Kahraman, L. W. Kracht, S. Vollmar, G. R. Fink, M. Schroeter, R. Goldbrunner, M. Schmidt and M. Maarouf: 11C-methionine positron emission tomographic imaging of biologic activity of a recurrent glioblastoma treated with stereotaxy-guided laser-induced interstitial Thermotherapy. In: Molecular Imaging 11, 4, 265-271 (2012).
doi: 10.2310/7290.2011.00046
Galldiks, N., W. von Tempelhoff, D. Kahraman, L. W. Kracht, S. Vollmar, G. R. Fink, M. Schroeter, R. Goldbrunner, M. Schmidt and M. Maarouf: 11C-methionine positron emission tomographic imaging of biologic activity of a recurrent glioblastoma treated with stereotaxy-guided laser-induced interstitial Thermotherapy. In: Molecular Imaging 11, 4, 265-271 (2012).
doi: 10.2310/7290.2011.00046
Galldiks, N., W. von Tempelhoff, D. Kahraman, L. W. Kracht, S. Vollmar, G. R. Fink, M. Schroeter, R. Goldbrunner, M. Schmidt and M. Maarouf: 11C-methionine positron emission tomographic imaging of biologic activity of a recurrent glioblastoma treated with stereotaxy-guided laser-induced interstitial Thermotherapy. In: Molecular Imaging 11, 4, 265-271 (2012).
doi: 10.2310/7290.2011.00046
Kahraman, D., A. Holstein, M. Scheffler, T. Zander, L. Nogova, A. A. Lammertsma, R. Boellaard, B. Neumaier, M. Dietlein, J. Wolf and C. Kobe: Tumor lesion glycolysis and tumor lesion proliferation for response prediction and prognostic differentiation in patients with advanced non-small cell lung cancer treated with erlotinib. In: Clinical Nuclear Medicine 37, 11, 1058-1064 (2012).
doi: 10.1097/RLU.0b013e3182639747
Kahraman, D., M. Scheffler, T. Zander, L. Nogova, A. A. Lammertsma, R. Boellaard, B. Neumaier, R. T. Ullrich, A. Holstein, M. Dietlein, J. Wolf and C. Kobe: Quantitative analysis of response to treatment with Erlotinib in advanced non–small cell lung cancer using 18F-FDG and 39-deoxy-39-18F-fluorothymidine PET. In: Journal of Nuclear Medicine 52, 12, 1-7 (2011).
doi: 10.2967/jnumed.111.094458
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.